-
【News】 CSO Terauchi Appointed as Member of the Industrial Structure Council of the Ministry of Economy, Trade and Industry
We are pleased to announce that our CSO, Jun Terauchi, who concurrently serves as the JMBC Steering Committee […]-
tsukiko.kurokawa@metagentx.com
-
-
【Recruitment Fraud Alert】 Phishing Scam Targeting Job Seekers
Recruitment fraud is on the rise, offering fake job opportunities. Metagen Therapeutics has become aware of in […]-
-
-
【Media Coverage】CSO Terauchi interviewed by Microbe Musings on Today’s Microbiome Therapeutics Industry in Asia
August 13, 2023- “Nurturing the Microbiome Therapeutics Industry in Asia,” a blog focusing on the latest news […]-
OhsawaKohei
-
-
【Press Release】Metagen Therapeutics Presents Latest Research at Microbiome Movement, the World’s Largest Microbiome Conference, and Other Major Conferences
Showcasing our progress of “gut microbiome therapy” research in Japan Yamagata, Japan, July 4, 2023–Metagen Th […]-
-
-
【Press Release】Metagen Therapeutics Completes Series A Financing Raising a Total of 1.7 Billion Yen
Yamagata, Japan, June 15, 2023-Metagen Therapeutics (President & CEO: Taku Nakahara), a company focusing o […]-
-
-
【Press Release】Metagen Therapeutics Raises JPY 1.1B in Initial Closing of Series A
Yamagata, Japan – Metagen Therapeutics (President and CEO: Taku Nakahara, PhD; Headquarters: Yamagata, Japan; […]-
-
-
【Press Release】Antibiotic Fecal Microbiota Transplantation for Ulcerative Colitis Patients Approved Under Japan’s Advanced Medical Care Program
January 4, 2023 JAPAN – Juntendo University (Bunkyo-ku, Tokyo, President: Hajime Arai) and Metagen Therapeutic […]-
IwataniAyako
-
-
【Press Release】 Metagen Therapeutics Raises 140M JPY in Pre-Series A For Its Microbiome Drug Discovery
10.06.2022 Yamagata, Japan—Metagen Therapeutics Inc. (President and CEO: Taku Nakahara; Headquarters: Yamagata […]-
-
-
【Press Release】Metagen Therapeutics and Juntendo University Establish a Joint Research Course, the ‘Microbiome Regeneration Course’
April 12, 2022 Yamagata, Japan—Metagen Therapeutics Inc. (President and CEO: Taku Nakahara; Headquarters: Yama […]-
-
-
【Press Release】Metagen Therapeutics, Inc. Joins Juntendo University In AMED’s ‘Project Focused on Developing Key Technology for Discovering and Manufacturing Drugs for Next-Generation Treatment and Diagnosis’ (Development of Next-Generation Drug Discovery Technology by Controlling Intestinal Microbiome)”
Promoting inflammatory bowel disease (IBD) seeds creation research with Juntendo University October 12, 2021 Y […]-
-
